Showing results (21-30 of 52) with videos related to
Sort By:
Pageof 6
Cancer Chemotherapy and Pharmacology|May 20, 2026
Antitumor efficacy and reduced systemic toxicity of palmitic acid-modified pirarubicin nanoparticles in miceKenji Tsukigawa, Takashi Hasegawa, Kindness Lomotey Commey, et al.Virus Research|March 18, 2023
A novel anti-HBV agent, E-CFCP, restores Hepatitis B virus (HBV)-induced senescence-associated cellular marker perturbation in human hepatocytesYuki Takamatsu, Sanae Hayashi, Hiroki Kumamoto, et al.Chembiochem : a European Journal of Chemical Biology|July 30, 2013
The Crosslink formation of 2'-OMe oligonucleotide containing 2-amino-6-vinylpurine protects mRNA from miRNA-mediated silencingShinya Hagihara, Wei-Chen Lin, Shuhei Kusano, et al.Plos One|June 7, 2018
Pharmacokinetic properties of a novel inosine analog, 4'-cyano-2'-deoxyinosine, after oral administration in ratsMai Hashimoto, Kazuaki Taguchi, Takako Ishiguro, et al.Journal of Pharmaceutical Sciences|May 8, 2022
Trimethoxy Trityl Groups as a Potent Substituent for Anti-cancer Cytidine Analog ProdrugsChihiro Ito, Kazuaki Taguchi, Yoshie Moroi, et al.Pharmaceuticals (Basel, Switzerland)|January 5, 2021
Synthesis and In Vitro Assessment of pH-Sensitive Human Serum Albumin Conjugates of PirarubicinKenji Tsukigawa, Shuhei Imoto, Keishi Yamasaki, et al.Bioorganic & Medicinal Chemistry Letters|May 23, 2012
Production of truncated protein by the crosslink formation of mRNA with 2'-OMe oligoribonucleotide containing 2-amino-6-vinylpurineShinya Hagihara, Shuhei Kusano, Wei-Chen Lin, et al.The Journal of Pharmacy and Pharmacology|March 13, 2018
Pharmacokinetics studies of 4'-cyano-2'-deoxyguanosine, a potent inhibitor of the hepatitis B virus, in ratsMai Hashimoto, Kazuaki Taguchi, Takako Ishiguro, et al.Journal of Pharmaceutical Sciences|December 12, 2018
Further Evidence Regarding the Important Role of Chlorine Atoms of Aripiprazole on Binding to the Site II Area of Human AlbuminKeiki Sakurama, Koji Nishi, Shuhei Imoto, et al.Chemical & Pharmaceutical Bulletin|January 3, 2024
Preparation and in Vitro Characterization of Fatty-Acid Modified Pirarubicin Nanosuspensions Stabilized by AlbuminTakashi Hasegawa, Kenji Tsukigawa, Kindness Commey, et al.Pageof 6